Navigation Links
Rigel Announces Participation at Two Investor Conferences
Date:2/28/2013

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower , chairman and chief executive officer, and Ryan Maynard , executive vice president and chief financial officer of Rigel, will participate at two upcoming investor conferences. Details of the events are as follows:

Cowen and Company 33rd Annual Health Care Conference 
Date: Wednesday, March 6 at 8:40 a.m. ET 
Location: Boston, MA 
Speaker: Ryan Maynard

25th Annual ROTH Conference 
Date: Monday, March 18 at 4:00 p.m. PT 
Location: Laguna Niguel, CA 
Speaker: James M. Gower

Both events will be webcast live and can be accessed at www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinic
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Rigel to Present at BIO CEO & Investor Conference
9. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
10. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
11. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
... experts recommend annual influenza vaccination for nearly 250 million ... rates fall far short every year. According to the ... 28,842 to 115,368 Denver residents will suffer from influenza ... immunization, the American Lung Association in Colorado (ALAC) is ...
... Oct. 15 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... underwritten public offering. Prior to closing, the underwriters exercised ... shares of common stock. As a result, Savient sold ... at a price to the public of $13.29 per ...
Cached Medicine Technology:American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 2American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 3American Lung Association in Colorado's Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 4Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option 2
(Date:10/22/2014)... Akeso Biomedical, Inc. , a ... of bacterial infections, microbial biofilms, and chronic wounds, announced ... of directors. , Dr. Sinskey is ... Massachusetts Institute of Technology, or MIT. He has been ... Sinskey also holds positions as Co-Director of the Malaysia-MIT ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The newly ... must-have source of thousands of facts, figures and forecasts ... and 68 medical sector forecast categories the Worldwide ... global, regional and national views on the worldwide medical ... , The report gives you data for 2010-2019, covering ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
... ... new public members of the board of the NJHCFFA. , ... (Vocus) January 18, 2010 --Simon J. Samaha, M.D., recently was confirmed by ... the New Jersey Health Care Facilities Financing Authority (The Authority). , , , , ,Dr. Samaha ...
... & CEO Gail McGovern to travel to Port-au-Prince ... Outside the damaged American Red Cross office in Croix Deprez , ... to clean and stitch wounds amidst the earthquake,s rubble. Outreach teams are ... as tarps, blankets, jerry cans for water and hygiene supplies. , ...
... complications may occur in children receiving cochlear implants, and ... and inner ear malformation, according to a report in ... Neck Surgery , one of the JAMA/Archives journals. ... a sense of sound to individuals who are deaf ...
... shouldn,t be overriding concern, study says , MONDAY, ... contribute to heart attack risk is better than simply ... U.S. researchers. , "We,ve been worrying too much about ... risk of heart disease," Dr. Rodney A. Hayward, director ...
... as other meds, study finds, , MONDAY, Jan. 18 ... rising faster than inflation, says a U.S. study, which ... traditional systemic therapies. , The researchers created a cost ... for psoriasis, a chronic autoimmune skin disease that affects ...
... that ,senior moments, don,t guarantee that dementia is on ... Mental lapses among older adults occur more often among ... finds. , Excessive daytime sleepiness, staring into space and ... often precede Alzheimer,s, say researchers from Washington University School ...
Cached Medicine News:Health News:Simon J. Samaha, M.D., Appointed Public Member of New Jersey Health Care Facilities Financing Authority 2Health News:American Red Cross Provides First Aid, Supplies in Croix Deprez 2Health News:American Red Cross Provides First Aid, Supplies in Croix Deprez 3Health News:Complications common, often linked to trauma in children receiving cochlear implants 2Health News:For Heart Health, Focus on Risk Factors 2Health News:Cost of Psoriasis Drugs Rising Faster Than Others 2Health News:Frequent Mental Lapses May Precede Alzheimer's 2Health News:Frequent Mental Lapses May Precede Alzheimer's 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: